Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Oral Minoxidil Appetite & Cravings Changes: What the Evidence Actually Shows

By
Published Updated Last reviewed
6 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Drug / Oral minoxidil tablets [1]
  • Appetite or cravings in the tablet label / Not listed; nausea and/or vomiting is listed [1]
  • Low-dose safety cohort / 1,404 patients; appetite and cravings not among reported effects [2]
  • Reported systemic effects in that cohort / Lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9%, headache 0.4%, periorbital edema 0.3%, insomnia 0.2% [2]
  • Heart-rate change / +2.67 beats/min with 5 mg/day or less [3]
  • Trial doses in hair-loss studies / 1 mg/day and 5 mg/day, both off-label [4][5]

Does oral minoxidil change appetite or cravings?

The oral minoxidil tablet label does not list increased appetite, reduced appetite or food cravings [1]. The label covers minoxidil tablets for hypertension, not a hair-loss product [1]. Its gastrointestinal adverse-reaction entry is nausea and/or vomiting [1]. In the 1,404-patient low-dose cohort, reported systemic effects were lightheadedness (1.7%), fluid retention (1.3%), tachycardia (0.9%), headache (0.4%), periorbital edema (0.3%) and insomnia (0.2%); appetite and cravings were not among them [2]. That study was retrospective with no control group, so it shows what was reported but cannot rule out a subtle effect [2].

What the label lists instead

The label warns about salt and water retention and possible congestive heart failure, and says body weight should be monitored closely [1]. At antihypertensive doses, temporary edema developed in 7% of patients who were not edematous at the start [1]. At low doses, fluid retention was reported in 1.3% of the 1,404 patients [2]. The label also says minoxidil increases heart rate and can worsen angina, and that a beta-blocker is usually required with antihypertensive doses to prevent tachycardia [1]. A 2025 meta-analysis of studies using 5 mg/day or less found a heart-rate increase of 2.67 beats/min (95% CI 0.34 to 5.01) [3]. None of these label entries is an appetite or craving effect [1].

What is the evidence and approval status?

A 2021 review of 17 studies and 634 patients concluded oral minoxidil was effective and well tolerated in healthy patients who had trouble with topical formulations, and that larger randomized dose-comparison studies are needed [6]. Randomized trials used 1 mg/day or 5 mg/day and reported hair density, hair diameter and safety [4][5]. Those doses are off-label. Oral minoxidil tablets are approved only for hypertension that is symptomatic or associated with target organ damage and not manageable with maximum doses of a diuretic plus two other antihypertensive drugs [1]. The label says use to promote hair growth, in any formulation, is not an approved indication [1].

Frequently asked questions

Does oral minoxidil increase appetite?
Increased appetite and cravings are not listed as adverse reactions for oral minoxidil tablets; nausea and/or vomiting is listed [1].
Can oral minoxidil cause weight gain?
It can cause fluid retention. The label warns of salt and water retention and says body weight should be monitored closely [1]. In the 1,404-patient low-dose cohort, fluid retention was reported in 1.3% [2].
Is oral minoxidil FDA-approved for hair loss?
No. The tablet label says use to promote hair growth, in any formulation, is not an approved indication; the tablets are approved only for severe hypertension [1].

References

  1. U.S. National Library of Medicine, DailyMed. Minoxidil tablets (oral), prescribing information. Minoxidil tablets (oral) label
  2. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
  3. Chen M, Weichert M, Guo W, Ruzic R, Briley J. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis. J Am Acad Dermatol. 2025;92(3):554-555. Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis
  4. Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial
  5. Asilian A, Farmani A, Saber M. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. J Cosmet Dermatol. 2024;23(3):949-957. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial
  6. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. Oral minoxidil treatment for hair loss: A review of efficacy and safety
Evidence overview for Oral Minoxidil Appetite & Cravings Changes: What the Evidence Actually Shows